Dr. med. Dr. rer. nat. Guranda Chitadze

Facts

Phone: +49-431-500-62274
E-Mail: guranda.chitadze@uksh.de
Website:
www.uksh.de/haematologielabor-kiel
Affiliations: Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel, Divison of Hematological Special Diagnostics / University Medical Center Schleswig-Holstein, Campus Kiel
Address: Langer Segen 8-10, 24105 Kiel

Curriculum vitae

Education/Training

Since 01/2017Residency, Department of Internal Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel (Prof. Dr. C. Baldus) German Approbation in human medicine (05/2018)
2007-2010Residency, Department of Allergy and Clinical Immunology, Tbilisi State Medical University Hospital, Georgia (Prof. Dr. Thelia)
2000-2006Student at the Medical Faculty of the Tbilisi State Medical University, Tbilisi, Georgia

Research Experience/Academic Appointments

04/2019Clinician-scientist within Evolutionary Medicine (CSEM), DFG-funded  “Modeling disease dynamics in leukemias in the context of therapy resistance”
Since 01/2017Post-doctoral researcher, Unit for Specialized Hematological Diagnostics, University Hospital Schleswig-Holstein, Campus Kiel (Prof. Dr. M. Brüggemann)
2013-2016PhD-student/Research associate, Institute of Immunology, Kiel, Germany (Prof. D. Kabelitz)
08/2013Promotion at the medical faculty of the university Kiel, Kiel, Germany
2010-2012MD-student, Institute of Immunology, Kiel, Germany (Prof. D. Kabelitz)

Important Scientific Prizes/Functions

Since 2020Member of parliament of the medical faculty of the university Kiel
Since 2019Membership of European Hematology Association
Since 2018Board member of promotion committee at the medical faculty of the university Kiel
Since 2017Member of EuroFlow Consortium
Since 2016Board member of the gender equality committee at the medical faculty of the university Kiel
Since 2011Membership of German association of Immunology
2011-2012IRTG scholarship for medical doctorate students, SFB 877, DFG foundation 
2010DAAD-scholarship for young scientist  

Research groups

P3
Chitadze / Brüggemann

MRD

Minimal residual disease characteristics and its immune system interaction in the context of treatment resistance

Project-related publications

P1, P3, P4, Z, INF

Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.

Bastian L, Beder T, Barz MJ, Bendig S, Bartsch L, Walter W, Wolgast N, Brändl B, Rohrandt C, Hansen BT, Hartmann AM, Iben K, Das Gupta D, Denker M, Zimmermann J, Wittig M, Chitadze G, Neumann M, Schneller F, Fiedler W, Steffen B, Stelljes M, Faul C, Schwartz S, Müller FJ, Cario G, Harder L, Haferlach C, Pfeifer H, Gökbuget N, Brüggemann M, Baldus CD.

PubMed (PMID: 38153913)
Blood
2023

Participating Institutes